March 01, 2023
5 min watch
Save
VIDEO: Vyzulta effective with both higher and lower baseline IOPs
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this Healio Video Perspective from the EnVision Summit, Constance O. Okeke, MD, MSCE, discusses the mechanism of action and efficacy of Vyzulta to treat glaucoma.
“When we talk about medication in general, a great checklist to think about is if the medication is effective, if it’s tolerable to the patients, if it is something that is able to be used in an easy fashion, so an easy regimen, and also if it is available and easy for patients to get and afford,” Okeke said. “Vyzulta does check all of these boxes.”
Published by:
Sources/Disclosures
Collapse
Source:
Okeke CO. Showcasing inflammation and IOP control with Bausch + Lomb. Presented at: EnVision Summit; Feb. 17-20, 2023; Puerto Rico.
Disclosures:
Okeke reports being a speaker for Bausch + Lomb.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.